New rapid infection tests can now get to market faster

US health regulators have created a new, faster approval path for advanced infection testing systems. This means companies can bring new diagnostic tools to hospitals and clinics more quickly.

For years, getting new medical devices approved meant navigating a slow, expensive process designed for older technologies. This change means that a specific type of modern diagnostic tool, which can quickly identify infections, will face fewer regulatory hurdles. This could speed up how fast doctors can get accurate diagnoses and start treatment.